APO Research

APO RESEARCH · REPORT

Period Cramp Pain Killer

Selected research

Market Analysis & Forecast

Global Period Cramp Pain Killer Market Analysis and Forecast 2026-2032

Market perspective

The global Period Cramp Pain Killer market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Period Cramp Pain Killer is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Period Cramp Pain Killer is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Period Cramp Pain Killer is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Period Cramp Pain Killer is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Period Cramp Pain Killer include SK&F, Johnson & Johnson, Bayer, Zambon, SSP CO, Sato Pharmaceutical, Lion Corporation, Kowa Company and GSK Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Period Cramp Pain Killer, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Period Cramp Pain Killer, also provides the revenue of main regions and countries. Of the upcoming market potential for Period Cramp Pain Killer, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Period Cramp Pain Killer revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Period Cramp Pain Killer market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Period Cramp Pain Killer revenue, projected growth trends, production technology, application and end-user industry.

Period Cramp Pain Killer Segment by Company

SK&F

Johnson & Johnson

Bayer

Zambon

SSP CO

Sato Pharmaceutical

Lion Corporation

Kowa Company

GSK Group

Daewoong

Arax Co

Period Cramp Pain Killer Segment by Type

NSAID

Acetaminophen

Period Cramp Pain Killer Segment by Application

Teenagers

Adults

Period Cramp Pain Killer Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Period Cramp Pain Killer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Period Cramp Pain Killer and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Period Cramp Pain Killer.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Period Cramp Pain Killer in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Period Cramp Pain Killer company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Period Cramp Pain Killer revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Period Cramp Pain Killer Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. NSAID Major Player Table 3. Acetaminophen Major Player Table 4. Global Period Cramp Pain Killer Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Teenagers Major Player Table 6. Adults Major Player Table 7. Period Cramp Pain Killer Industry Trends Table 8. Period Cramp Pain Killer Industry Drivers Table 9. Period Cramp Pain Killer Industry Opportunities and Challenges Table 10. Period Cramp Pain Killer Industry Restraints Table 11. Global Period Cramp Pain Killer Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Period Cramp Pain Killer Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Period Cramp Pain Killer Market Share by Region (2021-2026) Table 14. Global Period Cramp Pain Killer Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Period Cramp Pain Killer Market Share by Region (2027-2032) Table 16. Global Period Cramp Pain Killer Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Period Cramp Pain Killer Revenue Market Share by Players (2021-2026) Table 18. Global Period Cramp Pain Killer Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Period Cramp Pain Killer Key Players Headquarters & Area Served Table 20. Global Period Cramp Pain Killer Players, Product Type & Application Table 21. Global Period Cramp Pain Killer Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Period Cramp Pain Killer by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Period Cramp Pain Killer Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Period Cramp Pain Killer Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Period Cramp Pain Killer Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Period Cramp Pain Killer Revenue Market Share by Type (2021-2026) Table 28. Global Period Cramp Pain Killer Revenue Market Share by Type (2027-2032) Table 29. Global Period Cramp Pain Killer Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Period Cramp Pain Killer Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Period Cramp Pain Killer Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Period Cramp Pain Killer Revenue Market Share by Application (2021-2026) Table 33. Global Period Cramp Pain Killer Revenue Market Share by Application (2027-2032) Table 34. SK&F Company Information Table 35. SK&F Business Overview Table 36. SK&F Period Cramp Pain Killer Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. SK&F Period Cramp Pain Killer Product Portfolio Table 38. SK&F Recent Development Table 39. Johnson & Johnson Company Information Table 40. Johnson & Johnson Business Overview Table 41. Johnson & Johnson Period Cramp Pain Killer Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Johnson & Johnson Period Cramp Pain Killer Product Portfolio Table 43. Johnson & Johnson Recent Development Table 44. Bayer Company Information Table 45. Bayer Business Overview Table 46. Bayer Period Cramp Pain Killer Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Bayer Period Cramp Pain Killer Product Portfolio Table 48. Bayer Recent Development Table 49. Zambon Company Information Table 50. Zambon Business Overview Table 51. Zambon Period Cramp Pain Killer Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Zambon Period Cramp Pain Killer Product Portfolio Table 53. Zambon Recent Development Table 54. SSP CO Company Information Table 55. SSP CO Business Overview Table 56. SSP CO Period Cramp Pain Killer Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. SSP CO Period Cramp Pain Killer Product Portfolio Table 58. SSP CO Recent Development Table 59. Sato Pharmaceutical Company Information Table 60. Sato Pharmaceutical Business Overview Table 61. Sato Pharmaceutical Period Cramp Pain Killer Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Sato Pharmaceutical Period Cramp Pain Killer Product Portfolio Table 63. Sato Pharmaceutical Recent Development Table 64. Lion Corporation Company Information Table 65. Lion Corporation Business Overview Table 66. Lion Corporation Period Cramp Pain Killer Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Lion Corporation Period Cramp Pain Killer Product Portfolio Table 68. Lion Corporation Recent Development Table 69. Kowa Company Company Information Table 70. Kowa Company Business Overview Table 71. Kowa Company Period Cramp Pain Killer Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Kowa Company Period Cramp Pain Killer Product Portfolio Table 73. Kowa Company Recent Development Table 74. GSK Group Company Information Table 75. GSK Group Business Overview Table 76. GSK Group Period Cramp Pain Killer Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. GSK Group Period Cramp Pain Killer Product Portfolio Table 78. GSK Group Recent Development Table 79. Daewoong Company Information Table 80. Daewoong Business Overview Table 81. Daewoong Period Cramp Pain Killer Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Daewoong Period Cramp Pain Killer Product Portfolio Table 83. Daewoong Recent Development Table 84. Arax Co Company Information Table 85. Arax Co Business Overview Table 86. Arax Co Period Cramp Pain Killer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Arax Co Period Cramp Pain Killer Product Portfolio Table 88. Arax Co Recent Development Table 89. North America Period Cramp Pain Killer Revenue by Type (2021-2026) & (US$ Million) Table 90. North America Period Cramp Pain Killer Revenue by Type (2027-2032) & (US$ Million) Table 91. North America Period Cramp Pain Killer Revenue by Application (2021-2026) & (US$ Million) Table 92. North America Period Cramp Pain Killer Revenue by Application (2027-2032) & (US$ Million) Table 93. North America Period Cramp Pain Killer Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Period Cramp Pain Killer Revenue by Country (2021-2026) & (US$ Million) Table 95. North America Period Cramp Pain Killer Revenue by Country (US$ Million) & (2027-2032) Table 96. Europe Period Cramp Pain Killer Revenue by Type (2021-2026) & (US$ Million) Table 97. Europe Period Cramp Pain Killer Revenue by Type (2027-2032) & (US$ Million) Table 98. Europe Period Cramp Pain Killer Revenue by Application (2021-2026) & (US$ Million) Table 99. Europe Period Cramp Pain Killer Revenue by Application (2027-2032) & (US$ Million) Table 100. Europe Period Cramp Pain Killer Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Europe Period Cramp Pain Killer Revenue by Country (2021-2026) & (US$ Million) Table 102. Europe Period Cramp Pain Killer Revenue by Country (US$ Million) & (2027-2032) Table 103. China Period Cramp Pain Killer Revenue by Type (2021-2026) & (US$ Million) Table 104. China Period Cramp Pain Killer Revenue by Type (2027-2032) & (US$ Million) Table 105. China Period Cramp Pain Killer Revenue by Application (2021-2026) & (US$ Million) Table 106. China Period Cramp Pain Killer Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia Period Cramp Pain Killer Revenue by Type (2021-2026) & (US$ Million) Table 108. Asia Period Cramp Pain Killer Revenue by Type (2027-2032) & (US$ Million) Table 109. Asia Period Cramp Pain Killer Revenue by Application (2021-2026) & (US$ Million) Table 110. Asia Period Cramp Pain Killer Revenue by Application (2027-2032) & (US$ Million) Table 111. Asia Period Cramp Pain Killer Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Asia Period Cramp Pain Killer Revenue by Region (US$ Million) & (2021-2026) Table 113. Asia Period Cramp Pain Killer Revenue by Region (US$ Million) & (2027-2032) Table 114. SAMEA Period Cramp Pain Killer Revenue by Type (2021-2026) & (US$ Million) Table 115. SAMEA Period Cramp Pain Killer Revenue by Type (2027-2032) & (US$ Million) Table 116. SAMEA Period Cramp Pain Killer Revenue by Application (2021-2026) & (US$ Million) Table 117. SAMEA Period Cramp Pain Killer Revenue by Application (2027-2032) & (US$ Million) Table 118. SAMEA Period Cramp Pain Killer Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. SAMEA Period Cramp Pain Killer Revenue by Country (2021-2026) & (US$ Million) Table 120. SAMEA Period Cramp Pain Killer Revenue by Country (US$ Million) & (2027-2032) Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Period Cramp Pain Killer Image Figure 2. Global Period Cramp Pain Killer Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Period Cramp Pain Killer Market Size Share 2021 VS 2025 VS 2032 Figure 4. NSAID Image Figure 5. Acetaminophen Image Figure 6. Global Period Cramp Pain Killer Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Period Cramp Pain Killer Market Size Share 2021 VS 2025 VS 2032 Figure 8. Teenagers Image Figure 9. Adults Image Figure 10. Global Period Cramp Pain Killer Market Size (US$ Million) & (2021-2032) Figure 11. Global Period Cramp Pain Killer Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Period Cramp Pain Killer Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Period Cramp Pain Killer Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Period Cramp Pain Killer Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Period Cramp Pain Killer Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Period Cramp Pain Killer Revenue Market Share by Type (2021-2032) Figure 18. Global Period Cramp Pain Killer Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Period Cramp Pain Killer Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Period Cramp Pain Killer Revenue Market Share by Application (2021-2032) Figure 21. North America Period Cramp Pain Killer Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Period Cramp Pain Killer Revenue Share by Type (2021-2032) Figure 23. North America Period Cramp Pain Killer Revenue Share by Application (2021-2032) Figure 24. North America Period Cramp Pain Killer Revenue Share by Country (2021-2032) Figure 25. United States Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Period Cramp Pain Killer Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Period Cramp Pain Killer Revenue Share by Type (2021-2032) Figure 30. Europe Period Cramp Pain Killer Revenue Share by Application (2021-2032) Figure 31. Europe Period Cramp Pain Killer Revenue Share by Country (2021-2032) Figure 32. Germany Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Period Cramp Pain Killer Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Period Cramp Pain Killer Revenue Share by Type (2021-2032) Figure 42. China Period Cramp Pain Killer Revenue Share by Application (2021-2032) Figure 43. Asia Period Cramp Pain Killer Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Period Cramp Pain Killer Revenue Share by Type (2021-2032) Figure 45. Asia Period Cramp Pain Killer Revenue Share by Application (2021-2032) Figure 46. Asia Period Cramp Pain Killer Revenue Share by Region (2021-2032) Figure 47. Japan Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Period Cramp Pain Killer Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Period Cramp Pain Killer Revenue Share by Type (2021-2032) Figure 55. SAMEA Period Cramp Pain Killer Revenue Share by Application (2021-2032) Figure 56. SAMEA Period Cramp Pain Killer Revenue Share by Country (2021-2032) Figure 57. Brazil Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Period Cramp Pain Killer Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • NSAID
  • Acetaminophen
Applications
  • Teenagers
  • Adults
Companies covered
  • SK&F
  • Johnson & Johnson
  • Bayer
  • Zambon
  • SSP CO
  • Sato Pharmaceutical
  • Lion Corporation
  • Kowa Company
  • GSK Group
  • Daewoong
  • Arax Co

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Period Cramp Pain Killer Market by Type
  3. 1.2.1 Global Period Cramp Pain Killer Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 NSAID
  5. 1.2.3 Acetaminophen
  6. 1.3 Period Cramp Pain Killer Market by Application
  7. 1.3.1 Global Period Cramp Pain Killer Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Teenagers
  9. 1.3.3 Adults
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Period Cramp Pain Killer Market Dynamics
  1. 2.1 Period Cramp Pain Killer Industry Trends
  2. 2.2 Period Cramp Pain Killer Industry Drivers
  3. 2.3 Period Cramp Pain Killer Industry Opportunities and Challenges
  4. 2.4 Period Cramp Pain Killer Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Period Cramp Pain Killer Market Perspective (2021-2032)
  2. 3.2 Global Period Cramp Pain Killer Growth Trends by Region
  3. 3.2.1 Global Period Cramp Pain Killer Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Period Cramp Pain Killer Market Size by Region (2021-2026)
  5. 3.2.3 Global Period Cramp Pain Killer Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Period Cramp Pain Killer Revenue by Players
  2. 4.1.1 Global Period Cramp Pain Killer Revenue by Players (2021-2026)
  3. 4.1.2 Global Period Cramp Pain Killer Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Period Cramp Pain Killer Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Period Cramp Pain Killer Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Period Cramp Pain Killer Key Players Headquarters & Area Served
  7. 4.4 Global Period Cramp Pain Killer Players, Product Type & Application
  8. 4.5 Global Period Cramp Pain Killer Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Period Cramp Pain Killer Market CR5 and HHI
  11. 4.6.3 2025 Period Cramp Pain Killer Tier 1, Tier 2, and Tier 3
5 Period Cramp Pain Killer Market Size by Type
  1. 5.1 Global Period Cramp Pain Killer Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Period Cramp Pain Killer Revenue by Type (2021-2032)
  3. 5.3 Global Period Cramp Pain Killer Revenue Market Share by Type (2021-2032)
6 Period Cramp Pain Killer Market Size by Application
  1. 6.1 Global Period Cramp Pain Killer Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Period Cramp Pain Killer Revenue by Application (2021-2032)
  3. 6.3 Global Period Cramp Pain Killer Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 SK&F
  2. 7.1.1 SK&F Company Information
  3. 7.1.2 SK&F Business Overview
  4. 7.1.3 SK&F Period Cramp Pain Killer Revenue and Gross Margin (2021-2026)
  5. 7.1.4 SK&F Period Cramp Pain Killer Product Portfolio
  6. 7.1.5 SK&F Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson Period Cramp Pain Killer Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson Period Cramp Pain Killer Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 Bayer
  14. 7.3.1 Bayer Company Information
  15. 7.3.2 Bayer Business Overview
  16. 7.3.3 Bayer Period Cramp Pain Killer Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Bayer Period Cramp Pain Killer Product Portfolio
  18. 7.3.5 Bayer Recent Developments
  19. 7.4 Zambon
  20. 7.4.1 Zambon Company Information
  21. 7.4.2 Zambon Business Overview
  22. 7.4.3 Zambon Period Cramp Pain Killer Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Zambon Period Cramp Pain Killer Product Portfolio
  24. 7.4.5 Zambon Recent Developments
  25. 7.5 SSP CO
  26. 7.5.1 SSP CO Company Information
  27. 7.5.2 SSP CO Business Overview
  28. 7.5.3 SSP CO Period Cramp Pain Killer Revenue and Gross Margin (2021-2026)
  29. 7.5.4 SSP CO Period Cramp Pain Killer Product Portfolio
  30. 7.5.5 SSP CO Recent Developments
  31. 7.6 Sato Pharmaceutical
  32. 7.6.1 Sato Pharmaceutical Company Information
  33. 7.6.2 Sato Pharmaceutical Business Overview
  34. 7.6.3 Sato Pharmaceutical Period Cramp Pain Killer Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sato Pharmaceutical Period Cramp Pain Killer Product Portfolio
  36. 7.6.5 Sato Pharmaceutical Recent Developments
  37. 7.7 Lion Corporation
  38. 7.7.1 Lion Corporation Company Information
  39. 7.7.2 Lion Corporation Business Overview
  40. 7.7.3 Lion Corporation Period Cramp Pain Killer Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Lion Corporation Period Cramp Pain Killer Product Portfolio
  42. 7.7.5 Lion Corporation Recent Developments
  43. 7.8 Kowa Company
  44. 7.8.1 Kowa Company Company Information
  45. 7.8.2 Kowa Company Business Overview
  46. 7.8.3 Kowa Company Period Cramp Pain Killer Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Kowa Company Period Cramp Pain Killer Product Portfolio
  48. 7.8.5 Kowa Company Recent Developments
  49. 7.9 GSK Group
  50. 7.9.1 GSK Group Company Information
  51. 7.9.2 GSK Group Business Overview
  52. 7.9.3 GSK Group Period Cramp Pain Killer Revenue and Gross Margin (2021-2026)
  53. 7.9.4 GSK Group Period Cramp Pain Killer Product Portfolio
  54. 7.9.5 GSK Group Recent Developments
  55. 7.10 Daewoong
  56. 7.10.1 Daewoong Company Information
  57. 7.10.2 Daewoong Business Overview
  58. 7.10.3 Daewoong Period Cramp Pain Killer Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Daewoong Period Cramp Pain Killer Product Portfolio
  60. 7.10.5 Daewoong Recent Developments
  61. 7.11 Arax Co
  62. 7.11.1 Arax Co Company Information
  63. 7.11.2 Arax Co Business Overview
  64. 7.11.3 Arax Co Period Cramp Pain Killer Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Arax Co Period Cramp Pain Killer Product Portfolio
  66. 7.11.5 Arax Co Recent Developments
8 North America
  1. 8.1 North America Period Cramp Pain Killer Revenue (2021-2032)
  2. 8.2 North America Period Cramp Pain Killer Revenue by Type (2021-2032)
  3. 8.2.1 North America Period Cramp Pain Killer Revenue by Type (2021-2026)
  4. 8.2.2 North America Period Cramp Pain Killer Revenue by Type (2027-2032)
  5. 8.3 North America Period Cramp Pain Killer Revenue Share by Type (2021-2032)
  6. 8.4 North America Period Cramp Pain Killer Revenue by Application (2021-2032)
  7. 8.4.1 North America Period Cramp Pain Killer Revenue by Application (2021-2026)
  8. 8.4.2 North America Period Cramp Pain Killer Revenue by Application (2027-2032)
  9. 8.5 North America Period Cramp Pain Killer Revenue Share by Application (2021-2032)
  10. 8.6 North America Period Cramp Pain Killer Revenue by Country
  11. 8.6.1 North America Period Cramp Pain Killer Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Period Cramp Pain Killer Revenue by Country (2021-2026)
  13. 8.6.3 North America Period Cramp Pain Killer Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Period Cramp Pain Killer Revenue (2021-2032)
  2. 9.2 Europe Period Cramp Pain Killer Revenue by Type (2021-2032)
  3. 9.2.1 Europe Period Cramp Pain Killer Revenue by Type (2021-2026)
  4. 9.2.2 Europe Period Cramp Pain Killer Revenue by Type (2027-2032)
  5. 9.3 Europe Period Cramp Pain Killer Revenue Share by Type (2021-2032)
  6. 9.4 Europe Period Cramp Pain Killer Revenue by Application (2021-2032)
  7. 9.4.1 Europe Period Cramp Pain Killer Revenue by Application (2021-2026)
  8. 9.4.2 Europe Period Cramp Pain Killer Revenue by Application (2027-2032)
  9. 9.5 Europe Period Cramp Pain Killer Revenue Share by Application (2021-2032)
  10. 9.6 Europe Period Cramp Pain Killer Revenue by Country
  11. 9.6.1 Europe Period Cramp Pain Killer Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Period Cramp Pain Killer Revenue by Country (2021-2026)
  13. 9.6.3 Europe Period Cramp Pain Killer Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Period Cramp Pain Killer Revenue (2021-2032)
  2. 10.2 China Period Cramp Pain Killer Revenue by Type (2021-2032)
  3. 10.2.1 China Period Cramp Pain Killer Revenue by Type (2021-2026)
  4. 10.2.2 China Period Cramp Pain Killer Revenue by Type (2027-2032)
  5. 10.3 China Period Cramp Pain Killer Revenue Share by Type (2021-2032)
  6. 10.4 China Period Cramp Pain Killer Revenue by Application (2021-2032)
  7. 10.4.1 China Period Cramp Pain Killer Revenue by Application (2021-2026)
  8. 10.4.2 China Period Cramp Pain Killer Revenue by Application (2027-2032)
  9. 10.5 China Period Cramp Pain Killer Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Period Cramp Pain Killer Revenue (2021-2032)
  2. 11.2 Asia Period Cramp Pain Killer Revenue by Type (2021-2032)
  3. 11.2.1 Asia Period Cramp Pain Killer Revenue by Type (2021-2026)
  4. 11.2.2 Asia Period Cramp Pain Killer Revenue by Type (2027-2032)
  5. 11.3 Asia Period Cramp Pain Killer Revenue Share by Type (2021-2032)
  6. 11.4 Asia Period Cramp Pain Killer Revenue by Application (2021-2032)
  7. 11.4.1 Asia Period Cramp Pain Killer Revenue by Application (2021-2026)
  8. 11.4.2 Asia Period Cramp Pain Killer Revenue by Application (2027-2032)
  9. 11.5 Asia Period Cramp Pain Killer Revenue Share by Application (2021-2032)
  10. 11.6 Asia Period Cramp Pain Killer Revenue by Country
  11. 11.6.1 Asia Period Cramp Pain Killer Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Period Cramp Pain Killer Revenue by Country (2021-2026)
  13. 11.6.3 Asia Period Cramp Pain Killer Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Period Cramp Pain Killer Revenue (2021-2032)
  2. 12.2 SAMEA Period Cramp Pain Killer Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Period Cramp Pain Killer Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Period Cramp Pain Killer Revenue by Type (2027-2032)
  5. 12.3 SAMEA Period Cramp Pain Killer Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Period Cramp Pain Killer Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Period Cramp Pain Killer Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Period Cramp Pain Killer Revenue by Application (2027-2032)
  9. 12.5 SAMEA Period Cramp Pain Killer Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Period Cramp Pain Killer Revenue by Country
  11. 12.6.1 SAMEA Period Cramp Pain Killer Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Period Cramp Pain Killer Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Period Cramp Pain Killer Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research